PORTAL VERSUS PERIPHERAL CIRCULATING TUMOR CELLS AS PROGNOSTIC BIOMARKERS IN PATIENTS WITH STAGE I-III PANCREATIC DUCTAL ADENOCARCINOMA

被引：0
|
作者：
Prasoppokakorn, Thaninee
Chaiteerakij, Roongruedee
Buntho, Areeya
Ingrungruanglert, Praewphan
Israsena, Nipan
Ridtitid, Wiriyaporn
Angsuwatcharakon, Phonthep
Mekaroonkamol, Parit
Kongkam, Pradermchai
Rerknimitr, Rungsun
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
359
引用
收藏
页码：S63 / S64
页数：2
相关论文
共 50 条
  • [31] Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?
    Liu, Daniel S. K.
    Prado, Mireia Mato
    Giovannetti, Elisa
    Jiao, Long R.
    Krell, Jonathan
    Frampton, Adam E.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (07) : 553 - 558
  • [32] Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients
    Nitschke, Christine
    Markmann, Benedikt
    Tolle, Marie
    Kropidlowski, Jolanthe
    Belloum, Yassine
    Goetz, Mara R.
    Schluter, Hartmut
    Kwiatkowski, Marcel
    Sinn, Marianne
    Izbicki, Jakob
    Pantel, Klaus
    Gungor, Cenap
    Uzunoglu, Faik G.
    Wikman, Harriet
    CANCERS, 2022, 14 (18)
  • [33] Importance of triple tumor markers as biomarkers in patients with pancreatic ductal adenocarcinoma
    Takagi, Tadataka
    Nagai, Minako
    Nishiwada, Satoshi
    Terai, Taichi
    Yasuda, Satoshi
    Matsuo, Yasuko
    Doi, Shunsuke
    Kohara, Yuichiro
    Sho, Masayuki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (02): : 326 - 335
  • [34] ASO Author Reflections: Identification of Prognostic Factors for Stage-III Pancreatic Ductal Adenocarcinoma patients
    Chattopadhyay, Amrita
    Wu, Chien-Hui
    Tien, Yu-Wen
    Lu, Tzu-Pin
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1616 - 1617
  • [35] Racial disparities in the receipt of adjuvant chemotherapy in patients with resected stage I-III pancreatic adenocarcinoma.
    Sanford, Nina Niu
    Xu, Xiaohan
    Sher, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [36] Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma
    Sanford, Nina N.
    Aguilera, Todd A.
    Folkert, Michael R.
    Ahn, Chul
    Mahal, Brandon A.
    Zeh, Herbert
    Beg, Muhammad S.
    Mansour, John
    Sher, David J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (11): : 1292 - +
  • [37] Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
    Lee, Jee-Soo
    Park, Sung Sup
    Lee, Young Kyung
    Norton, Jeffrey A.
    Jeffrey, Stefanie S.
    MOLECULAR ONCOLOGY, 2019, 13 (08) : 1623 - 1650
  • [38] Diagnostic and prognostic value of KRAS mutations in circulating pancreatic ductal adenocarcinoma tumor DNA
    Yang, Xiaowei
    Xu, Wei
    Tian, Xiuyun
    Wu, Jianhui
    Lv, Ang
    Li, Chengpeng
    Guan, Xiaoya
    Qian, Honggang
    Hao, Chunyi
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 622 - 633
  • [39] Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
    Hansen, Frederik J.
    David, Paul
    Akram, Marina
    Knoedler, Samuel
    Mittelstaedt, Anke
    Merkel, Susanne
    Podolska, Malgorzata J.
    Swierzy, Izabela
    Rossdeutsch, Lotta
    Kloesch, Bettina
    Kouhestani, Dina
    Anthuber, Anna
    Benard, Alan
    Brunner, Maximilian
    Krautz, Christian
    Gruetzmann, Robert
    Weber, Georg F.
    CANCERS, 2023, 15 (02)
  • [40] Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice
    Zhao, Xudong
    Ma, Yongsu
    Dong, Xiu
    Zhang, Zhengkui
    Tian, Xiaodong
    Zhao, Xiaohang
    Yang, Yinmo
    HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (06) : 796 - +
12345